1. Home
  2. FSLR vs TEVA Comparison

FSLR vs TEVA Comparison

Compare FSLR & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Solar Inc.

FSLR

First Solar Inc.

HOLD

Current Price

$264.06

Market Cap

33.4B

Sector

Technology

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$32.98

Market Cap

39.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLR
TEVA
Founded
1999
1901
Country
United States
Israel
Employees
N/A
32842
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.4B
39.9B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
FSLR
TEVA
Price
$264.06
$32.98
Analyst Decision
Buy
Strong Buy
Analyst Count
27
8
Target Price
$236.42
$38.63
AVG Volume (30 Days)
2.8M
4.7M
Earning Date
04-30-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
18.22
N/A
EPS
3.22
N/A
Revenue
$5,219,376,000.00
N/A
Revenue This Year
$1.43
N/A
Revenue Next Year
$16.77
$2.97
P/E Ratio
$84.94
$28.19
Revenue Growth
24.09
N/A
52 Week Low
$141.50
$14.99
52 Week High
$320.95
$37.35

Technical Indicators

Market Signals
Indicator
FSLR
TEVA
Relative Strength Index (RSI) 52.13 43.90
Support Level $220.02 $30.53
Resistance Level $279.60 $35.37
Average True Range (ATR) 18.96 1.15
MACD -5.17 -0.14
Stochastic Oscillator 25.77 18.99

Price Performance

Historical Comparison
FSLR
TEVA

About FSLR First Solar Inc.

First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: